G&E Herbal Biotechnology Co Ltd
TPEX:4911
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
G&E Herbal Biotechnology Co Ltd
TPEX:4911
|
TW |
|
Western Uranium & Vanadium Corp
F:7WT
|
CA |
|
J
|
Jasmine Technology Solution PCL
SET:JTS
|
TH |
|
B
|
Birchtech Corp
AMEX:BCHT
|
US |
|
N
|
Newfoundland Discovery Corp
CNSX:NEWD
|
CA |
|
C
|
Critical Reagents Processing Corp
CNSX:CRPC
|
CA |
|
P
|
Permian Resources Corp
XMUN:YZ8
|
US |
|
F
|
Fonciere Inea SA
PAR:INEA
|
FR |
|
K
|
Kingsmen CMTI PCL
SET:K
|
TH |
|
A
|
Aim Commercial Growth Freehold and Leasehold Real Estate Investment Trust
SET:AIMCG
|
TH |
Dividends
Dividend Yield
G&E Herbal Biotechnology Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
G&E Herbal Biotechnology Co Ltd
Payout Ratio
G&E Herbal Biotechnology Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for G&E Herbal Biotechnology Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
G&E Herbal Biotechnology Co Ltd
| Average Annual Return | 11.86% |
| Standard Deviation of Annual Returns | 47.04% |
| Max Drawdown | -86% |
| Market Capitalization | 1.9B TWD |
| Shares Outstanding | 68 820 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
G&E Herbal Biotechnology Co Ltd's latest stock split occurred on Jul 28, 2026
The company executed a 1080-for-1000 stock split, meaning that for every 1000 shares held, investors received 1080 new shares.
Before the split, G&E Herbal Biotechnology Co Ltd traded at 32.5463 per share. Afterward, the share price was about 31.
The adjusted shares began trading on Jul 28, 2026. This was stock split number 4 in G&E Herbal Biotechnology Co Ltd's history, following the previous one in Jul 29, 2025.